CUV clinuvel pharmaceuticals limited

2025 YTD - Things are going well, page-9

  1. 356 Posts.
    lightbulb Created with Sketch. 193
    18 months is a shot in the dark. Buying will begin well before the revenues roll in.
    Sure, the buyback has been disappointing. For whatever reason, they've decided not to purchase shares at these levels. I'm still very happy they can, at any point, begin buying.
    Maybe they have market sensitive news?
    Maybe they're pursuing an acquisition?
    Maybe they're concerned about 2026-27 revenue growth and prefer to build cash?
    Not sure. Not very concerned. The price will increase when JPM wants to let it run. Buying 10,000 share a day will not disrupt JPM's script.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.07
Change
0.180(1.51%)
Mkt cap ! $601.9M
Open High Low Value Volume
$11.93 $12.19 $11.93 $394.3K 32.69K

Buyers (Bids)

No. Vol. Price($)
9 129 $12.06
 

Sellers (Offers)

Price($) Vol. No.
$12.08 295 7
View Market Depth
Last trade - 12.37pm 28/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.